Flare Therapeutics
Cambridge, United States · $290.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- flaretherapeutics.com
- Total Funding
- $290.0M
- Last Round
- $85.0M Series CJun 2026
- Rounds
- 3
About
Biotech startup developing precision small molecule medicines targeting transcription factors for cancer and other serious disorders.
Summary
Flare Therapeutics is a Biotech company based in Cambridge, United States. It has raised $290.0M in total across 3 rounds, most recently a $85.0M Series C round in Jun 2026. Investors include Third Rock Ventures, Nextech Invest and Pfizer Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...